• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • Clinical Trial Listings
    • What are Clinical Trials?
    • Become a Clinical Trial Volunteer
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Market Research
    • Benchmark Reports
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • White Papers
    • SOPs
  • White Papers
  • Clinical Trial Listings
  • Advertise
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Cenduit acquires Patient Reminders service

Cenduit acquires Patient Reminders service

June 24, 2013
CenterWatch Staff

Cenduit has acquired Patient Reminders, a service that allows clients/sponsors to reach patients directly with personalized messages and reminders about crucial aspects of their studies—increasing patient compliance and retention in clinical trials without purchasing special devices.

Cenduit clients now have the option to access a standalone product or utilize it as a component of their Interactive Response Technology (IRT) system. All IRT data can be integrated into the Patient Reminders platform to complete the package of patient participation, including arriving at appointments on time, taking medications on time, returning medications and drug accountability.

According to Cenduit, sites that can successfully engage patients through direct communication and reminders about crucial components of their studies will differentiate themselves in the industry and increase their probability of success. A recent study found a trial in which patients were reminded of appointments via text message saw a 40% increase in retention rates.

“We are excited about making our first acquisition—the first of many steps we are taking to create happier sites,” said Dr. Jogin Desai, CEO of Cenduit. “Happy sites are more productive and more profitable, and Cenduit sites are happier because we understand that technology is only part of the equation needed for their success. The other part is a thorough understanding and response to patient and sponsor needs through continually evolving innovative products and services. Acquiring Patient Reminders is one more example of how Cenduit enables site efficiency and patient compliance for superior outcomes in current and future trials.”

Mark Taggart, CEO of Patient Reminders, said it is a natural fit. “The technology we’ve developed simplifies and amplifies the effectiveness of patient communication throughout a clinical trial. It’s an honor to become part of the Cenduit portfolio.”

    Upcoming Events

    • 14Apr

      MAGI 2024: The Clinical Research Conference

    Featured Products

    • Surviving an FDA GCP Inspection

      Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

    • Best Practices for Clinical Trial Site Management

      Best Practices for Clinical Trial Site Management

    Featured Stories

    • Jonathan Seltzer

      Thought Leadership: Remote Patient Monitoring Gives New View of Safety in Cardiac Clinical Trials

    • Quality_Compass-360x240.png

      Ask the Experts: Applying Quality by Design to Protocols

    • Obesity Treatment Patient

      Clinical Trials Need Greater Representation of Obese Patients, Experts Say

    • Modernize-360x240.png

      FDA IT Modernization Plan Prioritizes Data-Sharing, AI, Collaboration and More

    Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

    The information you need to adapt your monitoring plan to changing times.

    Learn More Here
    • About Us
    • Contact Us
    • Privacy Policy
    • Do Not Sell or Share My Data

    Footer Logo

    300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

    Phone 703.538.7600 – Toll free 888.838.5578

    Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing